221 related articles for article (PubMed ID: 29496517)
1. Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.
Cackowski FC; Taichman RS
Bone; 2019 Feb; 119():82-86. PubMed ID: 29496517
[TBL] [Abstract][Full Text] [Related]
2. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
3. The prostate cancer bone marrow niche: more than just 'fertile soil'.
Pedersen EA; Shiozawa Y; Pienta KJ; Taichman RS
Asian J Androl; 2012 May; 14(3):423-7. PubMed ID: 22367179
[TBL] [Abstract][Full Text] [Related]
4. Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype.
Joseph J; Shiozawa Y; Jung Y; Kim JK; Pedersen E; Mishra A; Zalucha JL; Wang J; Keller ET; Pienta KJ; Taichman RS
Mol Cancer Res; 2012 Mar; 10(3):282-92. PubMed ID: 22241219
[TBL] [Abstract][Full Text] [Related]
5. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.
Shiozawa Y; Pedersen EA; Havens AM; Jung Y; Mishra A; Joseph J; Kim JK; Patel LR; Ying C; Ziegler AM; Pienta MJ; Song J; Wang J; Loberg RD; Krebsbach PH; Pienta KJ; Taichman RS
J Clin Invest; 2011 Apr; 121(4):1298-312. PubMed ID: 21436587
[TBL] [Abstract][Full Text] [Related]
6. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.
Shiozawa Y; Pienta KJ; Taichman RS
Clin Cancer Res; 2011 Sep; 17(17):5553-8. PubMed ID: 21676926
[TBL] [Abstract][Full Text] [Related]
8. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer and parasitism of the bone hematopoietic stem cell niche.
Yu C; Shiozawa Y; Taichman RS; McCauley LK; Pienta K; Keller E
Crit Rev Eukaryot Gene Expr; 2012; 22(2):131-48. PubMed ID: 22856431
[TBL] [Abstract][Full Text] [Related]
10. Mapping bone marrow niches of disseminated tumor cells.
Zhang W; Lo HC; Zhang XH
Sci China Life Sci; 2017 Oct; 60(10):1125-1132. PubMed ID: 29027156
[TBL] [Abstract][Full Text] [Related]
11. Biochemical Changes in the Niche Following Tumor Cell Invasion.
Decker AM; Cackowski FC; Jung Y; Taichman RS
J Cell Biochem; 2017 Aug; 118(8):1956-1964. PubMed ID: 27982511
[TBL] [Abstract][Full Text] [Related]
12. Disseminated tumor cells and dormancy in prostate cancer metastasis.
van der Toom EE; Verdone JE; Pienta KJ
Curr Opin Biotechnol; 2016 Aug; 40():9-15. PubMed ID: 26900985
[TBL] [Abstract][Full Text] [Related]
13. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS
Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470
[TBL] [Abstract][Full Text] [Related]
14. The biology and clinical implications of prostate cancer dormancy and metastasis.
Morrissey C; Vessella RL; Lange PH; Lam HM
J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605
[TBL] [Abstract][Full Text] [Related]
15. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
[TBL] [Abstract][Full Text] [Related]
16. The role of hematopoietic stem cell niche in prostate cancer bone metastasis.
Decker AM; Jung Y; Cackowski F; Taichman RS
J Bone Oncol; 2016 Sep; 5(3):117-120. PubMed ID: 27761370
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
18. Exploiting bone niches: progression of disseminated tumor cells to metastasis.
Muscarella AM; Aguirre S; Hao X; Waldvogel SM; Zhang XH
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720051
[TBL] [Abstract][Full Text] [Related]
19. The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.
Lam HM; Vessella RL; Morrissey C
Drug Discov Today Technol; 2014 Mar; 11():41-7. PubMed ID: 24847652
[TBL] [Abstract][Full Text] [Related]
20. The hematopoietic stem cell niche: What's so special about bone?
Frisch BJ
Bone; 2019 Feb; 119():8-12. PubMed ID: 29778716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
